Jazz Pharmaceuticals Partnering 2009-2014

Submitted by: Submitted by

Views: 59

Words: 728

Pages: 3

Category: Business and Industry

Date Submitted: 10/09/2014 10:37 PM

Report This Essay

ResearchMoz.us include new market research report" Jazz Pharmaceuticals Partnering 2009-2014" to its huge collection of research reports.

The Partnering Agreements with Jazz Pharmaceuticals 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.

Full Report With TOC @ http://www.researchmoz.us/jazz-pharmaceuticals-partnering-2009-2014-report.html

This report provides all the information you require to better understand Jazz Pharmaceuticals and its partnering interests and activities over the past seven years.

On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.

The report will be delivered in PDF format within 3 working days of receipt of order. If CD-Rom version purchased, the report will be sent by courier using express service.

One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.

Using this report, deal-makers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives.

The initial chapters of this report provide an orientation of big biotech's dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst

Chapter 2 lists the top 50 leading big biotech companies based on 2013 pharmaceutical revenues and their respective partnering activity.

Chapter 3 provides an overview of the leading partnering and M&A 2009 to present date based on headline value.

Chapter 4 provides details on how to approach big biotech companies with partnering opportunities whilst

Chapter 5 lists forthcoming partnering events...